CSIRO Publishing Home Books & CDs Journals About Us Shopping Cart
Reproduction, Fertility and Development
  An international journal at the forefront of reproduction and developmental science
You are here: Journals > Reproduction, Fertility and Development   
Search
 
 
  Advanced Search
   
Journal Home
General Information
Scope
Editorial Board
Editorial Contacts
Print Publication Dates
Online Content
For Authors
For Referees
How to Order

 Most Read
Visit our Most Read page regularly to keep up-to-date with the most downloaded papers in this journal.

 Early Alert
Subscribe to our email Early Alert or RSS feeds for the latest journal papers.

 

A decade of progress since the birth of Dolly

Ian Wilmut A B, Gareth Sullivan A and Jane Taylor A

A MRC Centre for Regenerative Medicine, University of Edinburgh, Chancellors Building, 49, Little France Crescent, Edinburgh EH16 4SB, UK.
B Corresponding author. Email: ian.wilmut@ed.ac.uk


Abstract

The greatest effect of the birth Dolly, the first cloned animal derived from an adult, has been in prompting biologists to consider ways of reprogramming adult nuclei to a pluripotent state directly. The first procedure depends upon use of viral vectors to introduce selected transcription factors, but this procedure is slow and very inefficient. Research in our laboratory has demonstrated that exposure of differentiated nuclei to an extract of embryo stem cells induces expression of key pluripotency genes within 8 h, suggesting that it may be possible to identify and use other factors to enhance direct reprogramming. A study of mechanisms that bring about changes in DNA methylation in early sheep embryos identified a developmental isoform of Dnmt1, the expression of which was limited to early stages of pregnancy. Reduction in the level of transcript of this isoform at the time of fertilisation caused sheep embryo development to cease at the early morula stage, revealing a key role for the isoform that remains to be characterised. The ability to obtain pluripotent cells from specific patients is providing important new opportunities to study inherited diseases when the causative mutation is not known. The initial objective of this research is not cell therapy, but to use cells with the characteristics of those in a patient who has inherited the disease to establish a high-throughput screen to identify drugs that are able to prevent progression of the symptoms of the disease. Research is in progress with cells from patients with amyotropic lateral sclerosis.

Reproduction, Fertility and Development 21(1) 95–100    doi:10.1071/RD08216
Published: 9 December 2008





   
Subscriber Login
Username:
Password:  

 View
Issue Contents
PDF (162 KB) $25
Export Citation
 Tools
Print
Email this page
    


 
Top  Email this page
 


Legal & Privacy | Sitemap | Contact Us | Help

CSIRO

© CSIRO 1996-2010